|
|
|
Volumn , Issue 312, 2009, Pages 17-27
|
|
Intravitreal bevacizumab for myopic choroidal neovascularization: short-term and 1-year results.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
ADULT;
AGED;
ARTICLE;
FEMALE;
HUMAN;
INTRAOCULAR DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDY;
SUBRETINAL NEOVASCULARIZATION;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
FEMALE;
HUMANS;
INJECTIONS, INTRAOCULAR;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
YOUNG ADULT;
|
|
EID: 75349111128
PISSN: 00810746
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
